Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kglip M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Kay's Biotech

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Kglip M 2mg/500mg Tablet

Diabexe Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and supplementary blood tests may be recommended to assess blood cell counts and liver function.

Primary Ingredients of Kglip M 2mg/500mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Kglip M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Kglip M 2mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Kglip M 2mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Kglip M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Kglip M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Kglip M 2mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with food.

How Kglip M 2mg/500mg Tablet works:

Kglip M 2mg/500mg tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates insulin release from the pancreas, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Kglip M 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Kglip M 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

The medication Kglip M (2mg/500mg tablets) is contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is either excessively low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Kglip M 2mg/500mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Kglip M 2mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Kglip M 2mg/500mg tablets cautiously, potentially requiring dose modification. Medical advice is essential. Low initial doses are typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Kglip M 2mg/500mg Tablet :

Should you forget to take your Kglip M 2mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Kglip M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Kglip M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Kglip M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Kglip M 2mg/500mg Tablets and seek immediate medical attention.
Kglip M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Kglip M 2mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Kglip M 2mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Kglip M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Kglip M 2mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Kglip M 2mg/500mg Tablet
56
MRP 68
17% off